| [1] |
Fulop T, Rákóczi I, Barna I. NovaSure impedance controlled endometrial ablation: Long－term follow－up results[M]. J Minim Invasive Gynecol, 2007, 14(1): 85－90.
|
| [2] |
Gallinat A. NovaSure impedance controlled system for endometrial ablation: Three－year follow－up on 107 patients[J]. Am J Obstet Gynecol, 2004, 191(5):1585-1589.
|
| [3] |
Patrick C, Caitriona M. NovaSure endometrial ablation: A review of 400 cases[J]. Gynecol Surg, 2011, 205(450):1-4.
|
| [4] |
Lukes AS, McBride RJ, Herring AH, et al. Improved premenstrual syndrome symptoms after NovaSure endometrial ablation[J]. J Minim Invasive Gynecol, 2011, 18(5):607-611.
|
| [5] |
Sabbah R, Desaulniers G. Use of the NovaSure impedance controlled endometrial ablation system in patients with intracavitary disease: 12－month follow－up results of a prospective, single－arm clinical study[J]. J Minim Invasive Gynecol, 2006, 13(5):467-471.
|
| [6] |
Kleijn JH, Engels R, Bourdrez P, et al. Five－year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation[J]. BJOG, 2008, 115(2):193-198.
|
| [7] |
Bongers MY, Bourdrez P, Mol BW, et al. Randomised controlled trial of bipolar radio－frequency endometrial ablation and balloon endometrial ablation[J]. BJOG, 2004, 111(10):1095-1102.
|
| [8] |
Laberge PY, Sabbah R, Fortin C, et al. Assessment and comparison of intraoperative and postoperative pain associated with NovaSure and ThermaChoice endometrial ablation systems[J]. J Am Assoc Gynecol Laparosc, 2003, 10(2):223-232.
|
| [9] |
Fadare O, Qin L, Martel M, et al. Pathology of the NovaSure (radio－frequency) impedance－controlled endometrial ablation system[J]. Arch Pathol Lab Med, 2005, 129(9):1175-1178.
|